Amedeo Smart

Free Medical Literature Service

 

Amedeo

Obstructive Lung Diseases
  Free Subscription

Articles published in
Thorax
    June 2026
  1. MOLBAEK-ENGBJERG T, Ali M, Horner D, Brustad N, et al
    Childhood haematological and immunoglobulin trajectories and risk of asthma at 18 years.
    Thorax. 2026 Jun 11:thorax-2026-224832. doi: 10.1136/thorax-2026-224832.
    >> Share

  2. WANG R, Daines L, Fowler SJ
    Preventing severe asthma exacerbations in at-risk patients: time for a rethink.
    Thorax. 2026 Jun 9:thorax-2026-225181. doi: 10.1136/thorax-2026-225181.
    >> Share

  3. GOYAL V, Vicendese D, Grimwood K, Yerkovich S, et al
    Paediatric bronchiectasis phenotypes and their association with clinical outcomes: development and validation in two prospective clinical cohorts.
    Thorax. 2026 Jun 8:thorax-2025-224359. doi: 10.1136/thorax-2025-224359.
    >> Share

  4. PALOMAR-CROS A, Abellan A, Raventos B, Pistillo A, et al
    Trends in asthma incidence and prevalence in 2 million children and adolescents in Catalonia, Spain, 2010-2024: a population-based cohort study.
    Thorax. 2026 Jun 8:thorax-2026-224985. doi: 10.1136/thorax-2026-224985.
    >> Share

    May 2026
  5. CARR MG, Ramakrishnan S
    Time for course correction? Rethinking oral steroids duration in acute asthma.
    Thorax. 2026 May 27:thorax-2025-224629. doi: 10.1136/thorax-2025-224629.
    >> Share

  6. SADATSAFAVI M, Miravitlles M, Quint JK, Perugini V, et al
    Development and validation of PRECISE-X model: predicting first severe exacerbation in COPD.
    Thorax. 2026;81:541-547.
    >> Share

  7. MATHIOUDAKIS AG, Bate S, Chatzimavridou-Grigoriadou V, Sivapalan P, et al
    Disproportionate increase in COPD exacerbation risk for 3 months after discontinuing LAMA or ICS: insights from the FLAME trial.
    Thorax. 2026;81:533-540.
    >> Share

  8. FARLEY C, Newman ANL, Phillips SM, Smith-Turchyn J, et al
    Measurement properties of the sit-to-stand test in community-dwelling people with chronic obstructive pulmonary disease: a COSMIN systematic review.
    Thorax. 2026;81:581-590.
    >> Share

  9. SHAW D, Pink K, McDowell PJ, Fardon T, et al
    Never say die: making a death from asthma a never event.
    Thorax. 2026 May 8:thorax-2025-224234. doi: 10.1136/thorax-2025-224234.
    >> Share

  10. SHINNERS O, Farrell T, Doyle D, Maher M, et al
    Beyond the wheeze: unveiling a rare diagnosis behind the asthma mask.
    Thorax. 2026 May 4:thorax-2025-224375. doi: 10.1136/thorax-2025-224375.
    >> Share

    April 2026
  11. HARDEE IJ, Monuteaux MC, Hoffmann RM, Hirsch AW, et al
    Trends in asthma-related paediatric mortality.
    Thorax. 2026 Apr 29:thorax-2025-224686. doi: 10.1136/thorax-2025-224686.
    >> Share

  12. MUISER S, Mullerova H, Belton L, Rusibamayila N, et al
    Association of blood eosinophils and exhaled nitric oxide with exacerbations in patients with asthma, COPD and asthma+COPD: the NOVELTY study.
    Thorax. 2026 Apr 21:thorax-2025-223646. doi: 10.1136/thorax-2025-223646.
    >> Share

  13. POPOVIC M, Maule M, Moccia C, Isaevska E, et al
    Maternal eating disorders and respiratory outcomes in childhood: findings from the EU Child Cohort Network.
    Thorax. 2026;81:464-473.
    >> Share

  14. SMITH TA, Roberts MM, Luckett T, Cho JG, et al
    Multidisciplinary, non-pharmacological breathlessness intervention service for patients with moderately severe to severe COPD: a randomised controlled trial.
    Thorax. 2026;81:420-429.
    >> Share

  15. NAESILLA N, Quint JK, Zuber V
    Understanding the bidirectional relationship between chronic respiratory disease and cardiovascular disease using genetic evidence.
    Thorax. 2026;81:447-456.
    >> Share

  16. WILSON AM, Musgrave SD, Smith JR, Noble M, et al
    At-risk registers integrated into primary care to stop asthma crises in the UK: cluster randomised controlled trial with economic evaluation.
    Thorax. 2026 Apr 15:thorax-2025-223973. doi: 10.1136/thorax-2025-223973.
    >> Share

  17. LAI CC, Chen CH, Wang YH, Wang CY, et al
    Association between overuse of short-acting beta2-agonists and the risk of major adverse cardiovascular events among patients with asthma.
    Thorax. 2026 Apr 15:thorax-2024-222204. doi: 10.1136/thorax-2024-222204.
    >> Share

    March 2026
  18. LEWIS A, Varkonyi-Sepp J, Healey N, Ainsworth B, et al
    An asthma-related anxiety intervention appropriate for the shift to digitalised care.
    Thorax. 2026 Mar 18:thorax-2026-224744. doi: 10.1136/thorax-2026-224744.
    >> Share

  19. MARSDEN P, Smith JA, Birring SS, Gruffydd-Jones K, et al
    Aligning management of chronic cough in asthma with BTS/NICE/SIGN guidance.
    Thorax. 2026 Mar 13:thorax-2025-224508. doi: 10.1136/thorax-2025-224508.
    >> Share

  20. ZHANG Y, Ye Z, Yang S, Zhang Y, et al
    Proteomics-based risk prediction and drug targets identification for chronic obstructive pulmonary disease.
    Thorax. 2026;81:311-319.
    >> Share

  21. BROWN SE, Wootton S, Dale MT, Alison JA, et al
    Mobile health pulmonary rehabilitation (m-PR): a randomised controlled equivalence trial.
    Thorax. 2026;81:302-310.
    >> Share

  22. SHAH PA, Diver S, Brightling CE
    Global asthma and pest control: bugs and WASPs.
    Thorax. 2026 Mar 3:thorax-2026-224743. doi: 10.1136/thorax-2026-224743.
    >> Share

    February 2026
  23. CROOKS MG, Sykes DL, Horne RR, Cummings H, et al
    2024 BTS/NICE/SIGN asthma guidelines have the potential to improve UK asthma outcomes, but we must act now.
    Thorax. 2026 Feb 26:thorax-2025-223465. doi: 10.1136/thorax-2025-223465.
    >> Share

  24. DOLL R
    Republished: Helium in the Treatment of Asthma.
    Thorax. 2026;81:229-237.
    >> Share

  25. LU X, Pei Y, Geng Y, Fan Y, et al
    Adherence to the EAT-Lancet diet, plasma proteomics and the risk of chronic obstructive pulmonary disease.
    Thorax. 2026;81:282-291.
    >> Share

  26. YIN Y, Mehareen J, Sadatsafavi M, Brigham E, et al
    Factors associated with guideline-concordant maintenance inhaled medication for COPD: a population-based, longitudinal cohort study.
    Thorax. 2026;81:246-256.
    >> Share

  27. POLLOCK J, Huang JTJ, Shuttleworth M, Long MB, et al
    Clinical, molecular and microbial characterisation of the eosinophilic endotype of bronchiectasis: data from the EMBARC-BRIDGE study.
    Thorax. 2026 Feb 13:thorax-2025-223305. doi: 10.1136/thorax-2025-223305.
    >> Share

  28. ARBIV OA, Thornton CS
    Granules of truth: unpacking the eosinophilic endotype in bronchiectasis.
    Thorax. 2026 Feb 13:thorax-2025-224609. doi: 10.1136/thorax-2025-224609.
    >> Share

    January 2026
  29. TAYLOR SL, Brooks CR, Pembrey L, Manning SK, et al
    Airway microbiota in young people across four continents differ by country, asthma status and inflammatory phenotype.
    Thorax. 2026 Jan 30:thorax-2025-222965. doi: 10.1136/thorax-2025-222965.
    >> Share

  30. PROCHASKA J, Rubinstein M, Perdok R, Blumenstein B, et al
    Cytisinicline for smoking cessation in individuals with self-reported COPD: a post hoc analysis of the ORCA-2 and ORCA-3 trials.
    Thorax. 2026;81:164-169.
    >> Share

  31. LIU J, Perret JL, Lodge CJ, Vicendese D, et al
    Paternal prepubertal passive smoke exposure is related to impaired lung function trajectories from childhood to middle age in their offspring.
    Thorax. 2026;81:131-139.
    >> Share

  32. BONNERT M, Nash S, Andersson EM, Bergstrom SEE, et al
    Online cognitive behaviour therapy for asthma-related anxiety: a randomised controlled trial.
    Thorax. 2026 Jan 6:thorax-2025-223886. doi: 10.1136/thorax-2025-223886.
    >> Share

    December 2025
  33. ALWADANI F, Ellis PR, Newnham M, de Soyza J, et al
    Pulmonary rehabilitation and quality of life in alpha-1 antitrypsin deficiency: findings from a retrospective cohort study.
    Thorax. 2025;81:78-80.
    >> Share

  34. YII A, Tay TR, Lee KCH, Chew SY, et al
    Blood eosinophil-guided systemic corticosteroid duration in adults hospitalised for asthma exacerbation: a randomised, controlled, open-label, non-inferiority trial.
    Thorax. 2025 Dec 3:thorax-2025-223961. doi: 10.1136/thorax-2025-223961.
    >> Share

    November 2025
  35. BALASUBRAMANIAN A, Hemnes AR, Brittain EL, Annis J, et al
    Disproportionate impairment in diffusing capacity predicts pulmonary hypertension with an elevated pulmonary vascular resistance in COPD.
    Thorax. 2025 Nov 27:thorax-2025-223921. doi: 10.1136/thorax-2025-223921.
    >> Share

  36. VERSTRAETE K, Gyselinck I, Huts H, Djamin RS, et al
    Identifying azithromycin responders with an individual treatment effect model in COPD.
    Thorax. 2025;80:900-908.
    >> Share

  37. SMITH LJ, Marshall H, Jakymelen D, Biancardi A, et al
    (129)Xe-MRI ventilation and acinar abnormalities highlight the significance of spirometric dysanapsis: findings from the NOVELTY ADPro UK substudy.
    Thorax. 2025;80:909-917.
    >> Share

  38. ATUG E, Trudzinski FC, Holland A, Grah C, et al
    Sex differences in outcome after endoscopic lung volume reduction (ELVR) in patients with emphysema: a retrospective analysis of the German Lung Emphysema Registry (LER e.V.).
    Thorax. 2025 Nov 13:thorax-2025-223559. doi: 10.1136/thorax-2025-223559.
    >> Share

  39. MARTINS COSTA GOMES G, Collison AM, Karmaus WJJ, Da Silva Sena CR, et al
    Association between maternal asthma and impaired infant lung function is diminished by inhaled corticosteroid use in pregnancy.
    Thorax. 2025 Nov 9:thorax-2025-223539. doi: 10.1136/thorax-2025-223539.
    >> Share

    October 2025
  40. LUNDHOLM C, Caffrey Osvald E, Rhedin S, Almqvist C, et al
    Maternal BMI and smoking partly explain the association between maternal socio-economic position and offspring asthma.
    Thorax. 2025 Oct 28:thorax-2025-223330. doi: 10.1136/thorax-2025-223330.
    >> Share

  41. XIA Y
    Why asthma progresses to COPD: environmental and genetic drivers.
    Thorax. 2025 Oct 21:thorax-2025-224038. doi: 10.1136/thorax-2025-224038.
    >> Share

  42. LANGLEY R, Corr M, Foster S, Weir E, et al
    New NICE asthma guideline: evidence-based gold standard approach or unachievable utopia?
    Thorax. 2025 Oct 20:thorax-2025-223970. doi: 10.1136/thorax-2025-223970.
    >> Share

  43. KOFOD LM, Hansen EF, Brocki BC, Kristensen MT, et al
    Optimised oxygenation improves functional capacity during daily activities in patients with COPD on long-term oxygen therapy: a randomised crossover trial.
    Thorax. 2025;80:803-809.
    >> Share

  44. SHIROSHITA A
    Clarifying the distinct risk factors of atopy and asthma in childhood.
    Thorax. 2025 Oct 8:thorax-2025-223533. doi: 10.1136/thorax-2025-223533.
    >> Share

  45. LIVIERO F
    Occupational asthma: still an underestimated burden?
    Thorax. 2025 Oct 5:thorax-2025-223499. doi: 10.1136/thorax-2025-223499.
    >> Share

  46. KAMINSKY DA
    Home monitoring of asthma using oscillometry: seeking the signal in the noise.
    Thorax. 2025 Oct 5:thorax-2025-223595. doi: 10.1136/thorax-2025-223595.
    >> Share

    September 2025
  47. ZHANG X, Hartman TJ, Adgent M, Moore P, et al
    Maternal prenatal carotenoids and child lung function: exploration of modifying factors.
    Thorax. 2025;80:748-755.
    >> Share

  48. ZHANG W, Chen B, Shima M, Zhao C, et al
    PM(2.5) as a risk factor for sleep oxygen desaturation in COPD: identifying susceptible individuals by smoking and inflammatory phenotypes.
    Thorax. 2025;80:683-692.
    >> Share

  49. SYKES DL, Clarkson MD, Negbenebor A, Cummings H, et al
    Impact of regional asthma guidelines on SABA prescribing patterns across England: an interrupted time series analysis.
    Thorax. 2025 Sep 2:thorax-2025-223239. doi: 10.1136/thorax-2025-223239.
    >> Share

    August 2025
  50. KIMURA Y, Jo T, Inoue N, Suzukawa M, et al
    Gabapentinoids and risk for asthma exacerbations: a nationwide retrospective cohort study.
    Thorax. 2025 Aug 24:thorax-2025-223240. doi: 10.1136/thorax-2025-223240.
    >> Share

  51. POTTINGER T, Liu Z, Liu L, Buschur KL, et al
    Serum IgA isotypes are associated with percent emphysema, wall thickness and lung function decline.
    Thorax. 2025 Aug 22:thorax-2025-222990. doi: 10.1136/thorax-2025-222990.
    >> Share

  52. PEPIN JL, Herquelot E, Denis H, Josseran A, et al
    Impact of long-term non-invasive ventilation on severe exacerbations and survival in COPD: a French nationwide cohort study using multistate models.
    Thorax. 2025;80:616-623.
    >> Share

  53. MATHIOUDAKIS AG, Higham A, Bate S, Chatzimavridou-Grigoriadou V, et al
    Reduced treatment response to inhaled corticosteroids in current smokers with COPD, regardless of blood eosinophil count: insights from the FLAME trial.
    Thorax. 2025;80:658-661.
    >> Share

  54. ALARCON-MARTINEZ T, Mainzer RM, Ranganathan S, Doyle LW, et al
    Spirometry phenotypes at 8 years in children born extremely preterm or with extremely low birth weight.
    Thorax. 2025 Aug 11:thorax-2024-222602. doi: 10.1136/thorax-2024-222602.
    >> Share

    July 2025
  55. LI G, Zhang K, Yang T, Jin J, et al
    Air pollution, genetic susceptibility and risk of progression from asthma to COPD.
    Thorax. 2025 Jul 21:thorax-2024-222871. doi: 10.1136/thorax-2024-222871.
    >> Share

  56. KEMP PR, Griffiths M, Polkey MI, Sathyapala A, et al
    Variability in sensitivity to inflammation in muscle and lung of patients with COPD may underlie susceptibility to lung function decline.
    Thorax. 2025;80:520-529.
    >> Share

  57. COLAK Y, Nordestgaard BG, Lange P, Afzal S, et al
    Sex differences in COPD in relation to smoking exposure: a population-based cohort study.
    Thorax. 2025;80:512-519.
    >> Share

    June 2025
  58. RUTTER CE, Mpairwe H, Figueiredo CA, Njoroge M, et al
    Risk factors for atopic and non-atopic asthma in school-age children from high-income and low- and middle-income countries.
    Thorax. 2025 Jun 24:thorax-2024-222118. doi: 10.1136/thorax-2024-222118.
    >> Share

  59. HOANG MT, Wong A, Hardaker K, Peiris S, et al
    Day-to-day variability indices improve utility of oscillometry in paediatric asthma.
    Thorax. 2025 Jun 24:thorax-2024-222744. doi: 10.1136/thorax-2024-222744.
    >> Share

  60. JIANG M, Zhang Y, Liu T, Hong X, et al
    Circulating miRNAs and childhood asthma ICS response: a stratified analysis in the intervention arm of an RCT with vitamin D effect modification.
    Thorax. 2025 Jun 4:thorax-2024-222618. doi: 10.1136/thorax-2024-222618.
    >> Share

    May 2025
  61. USMANI O, Verbanck S
    Structure-function-treatment relationships of aerosol deposition in patients with severe asthma.
    Thorax. 2025 May 22:thorax-2025-223228. doi: 10.1136/thorax-2025-223228.
    >> Share

  62. KHOR YH, Palm A, Wong AW, Guler SA, et al
    Effects of long-term oxygen therapy on acute exacerbation and hospital burden: the national DISCOVERY study.
    Thorax. 2025;80:378-384.
    >> Share

  63. KNOX-BROWN B, Kon FC, Sylvester KP, Jha A, et al
    Effect of time of day and seasonal variation on bronchodilator responsiveness: the SPIRO-TIMETRY study.
    Thorax. 2025;80:395-397.
    >> Share

    April 2025
  64. ALIF SM, Benke G, Kromhout H, Abramson MJ, et al
    Occupational exposures and incidence of asthma over two decades in the European Community Respiratory Health Survey.
    Thorax. 2025 Apr 29:thorax-2024-222307. doi: 10.1136/thorax-2024-222307.
    >> Share

  65. RUPANI H
    Is this the unified asthma guideline we've been waiting for?
    Thorax. 2025 Apr 24:thorax-2025-223056. doi: 10.1136/thorax-2025-223056.
    >> Share

  66. BERGMANN M, Andersen ZJ, Massling A, Loft S, et al
    Short-term exposure to ultrafine particles and asthma hospital admissions in children in Copenhagen, Denmark.
    Thorax. 2025 Apr 24:thorax-2024-222465. doi: 10.1136/thorax-2024-222465.
    >> Share


  67. BTS/NICE/SIGN joint guideline on asthma: diagnosis, monitoring and chronic asthma management (November 2024) - summary of recommendations.
    Thorax. 2025 Apr 24:thorax-2024-222910. doi: 10.1136/thorax-2024-222910.
    >> Share

  68. WANG R, Maidstone R, Singh D, Ray D, et al
    The impact of dosage timing for inhaled corticosteroids in asthma: a randomised three-way crossover trial.
    Thorax. 2025 Apr 15:thorax-2024-222073. doi: 10.1136/thorax-2024-222073.
    >> Share

  69. SMALLCOMBE N, Russell RE
    Chronotherapy in asthma: BD or not BD? That is the question.
    Thorax. 2025 Apr 15:thorax-2025-223094. doi: 10.1136/thorax-2025-223094.
    >> Share

  70. CHO EE, Maclagan LC, Chu A, Croxford R, et al
    Impact of COPD on cardiovascular risk factors and outcomes in people with established cardiovascular disease.
    Thorax. 2025;80:291-299.
    >> Share

  71. MARCALO R, Rodrigues G, Pinheiro M, Neto S, et al
    Functional impairment in COPD can be predicted using genomic-derived data.
    Thorax. 2025;80:283-290.
    >> Share

  72. WHITTAKER H, Kramer Fiala Machado A, Hatam S, Cook S, et al
    Incidence and prevalence of asthma, chronic obstructive pulmonary disease and interstitial lung disease between 2004 and 2023: harmonised analyses of longitudinal cohorts across England, Wales, South-East Scotland and Northern Ireland.
    Thorax. 2025 Apr 8:thorax-2024-222699. doi: 10.1136/thorax-2024-222699.
    >> Share

    March 2025
  73. RAGUNAYAKAM N, Thakar A, Sadafi H, Venegas Garrido C, et al
    Computational fluid dynamics model predictions of inhaled corticosteroid deposition in patients with severe asthma.
    Thorax. 2025 Mar 27:thorax-2024-222444. doi: 10.1136/thorax-2024-222444.
    >> Share

  74. POLLOCK J, Polverino E, Dhar R, Dimakou K, et al
    Use of inhaled corticosteroids in bronchiectasis: data from the European Bronchiectasis Registry (EMBARC).
    Thorax. 2025 Mar 23:thorax-2024-221825. doi: 10.1136/thorax-2024-221825.
    >> Share

  75. MUBANGA M, Gong T, Smew AI, Wikstrom A, et al
    Association between asthma and type 2 diabetes in a Swedish adult population: a register-based cross-sectional study.
    Thorax. 2025 Mar 23:thorax-2024-222819. doi: 10.1136/thorax-2024-222819.
    >> Share

  76. STORGAARD PETERSEN R, Hallas H, Brustad N, Chawes B, et al
    Short-term efficacy of inhaled short-acting beta-2-agonists for acute wheeze/asthma symptoms in preschool-aged children: a systematic review and meta-analysis.
    Thorax. 2025 Mar 23:thorax-2024-222760. doi: 10.1136/thorax-2024-222760.
    >> Share

  77. THOMPSON C, Middleton PG
    Inhaled corticosteroids may be useful in bronchiectasis with peripheral blood eosinophilia.
    Thorax. 2025 Mar 23:thorax-2025-223053. doi: 10.1136/thorax-2025-223053.
    >> Share

  78. RAVELING T, Boersma R, Wijkstra PJ, Duiverman ML, et al
    Clinical benefit of chronic non-invasive ventilation in severe stable COPD: a matter of persistent hypercapnia improvement.
    Thorax. 2025;80:202-208.
    >> Share

  79. GLOECKL R, Spielmanns M, Stankeviciene A, Plidschun A, et al
    Smartphone application-based pulmonary rehabilitation in COPD: a multicentre randomised controlled trial.
    Thorax. 2025;80:209-217.
    >> Share

  80. MACHADO A, Dias C, Paixao C, Goncalves AP, et al
    Short-term effects of home-based pulmonary rehabilitation during outpatient-managed exacerbations of COPD: a randomised controlled trial.
    Thorax. 2025;80:218-226.
    >> Share

  81. BAILEY G, Ridge CA
    Pulmonary microvascular blood volume and emphysema: in vivo link shown in the MESA cohort.
    Thorax. 2025 Mar 13:thorax-2025-223133. doi: 10.1136/thorax-2025-223133.
    >> Share

  82. BAE E, Park HJ, Park H, Lee JK, et al
    Early clinical remission and its role in lung function decline and exacerbation in adult Korean patients with asthma.
    Thorax. 2025 Mar 6:thorax-2024-222679. doi: 10.1136/thorax-2024-222679.
    >> Share

    February 2025
  83. KIVISTO JE, Protudjer JLP, Ekstrom S, Karjalainen J, et al
    Adult asthma hospitalisations decreased markedly in Finland and Sweden between 2006 and 2022.
    Thorax. 2025 Feb 8:thorax-2024-222417. doi: 10.1136/thorax-2024-222417.
    >> Share

    January 2025
  84. IOANNIDES AE, Kallis C, Whittaker HR, Quint JK, et al
    Inhaled corticosteroids and major cardiovascular events in people with chronic obstructive pulmonary disease.
    Thorax. 2025;80:67-75.
    >> Share

  85. VAN DER VEER T, Andrinopoulou ER, Braunstahl GJ, Charbonnier JP, et al
    Association between automatic AI-based quantification of airway-occlusive mucus plugs and all-cause mortality in patients with COPD.
    Thorax. 2025;80:105-108.
    >> Share

  86. DOUMAT G, El Zein J, Mehta GD, Zhu Z, et al
    Association between vitamin D status at 3 years and eosinophilic asthma in 6-year-old children with a history of severe bronchiolitis.
    Thorax. 2025 Jan 6:thorax-2024-222099. doi: 10.1136/thorax-2024-222099.
    >> Share

    December 2024
  87. HERRON M, Roche S, Fraughen DD, Heeney RC, et al
    Optimising bronchoalveolar lavage: lessons from alpha-1 antitrypsin deficiency.
    Thorax. 2024;80:24-31.
    >> Share

  88. LAVOIE G, Howell I, Melhorn J, Borg C, et al
    Effects of azithromycin in severe eosinophilic asthma with concomitant monoclonal antibody treatment.
    Thorax. 2024 Dec 18:thorax-2024-221977. doi: 10.1136/thorax-2024-221977.
    >> Share

  89. GRAUL EL, Janson C
    Cost-related nonadherence to medication among people with asthma in the United States: findings that reinforce the relevance of history and healthcare reform.
    Thorax. 2024 Dec 9:thorax-2024-222662. doi: 10.1136/thorax-2024-222662.
    >> Share

  90. HUNG CT, Erickson SR, Wu CH
    Cost-related non-adherence to medications among adults with asthma in the USA, 2011-2022.
    Thorax. 2024 Dec 9:thorax-2024-221778. doi: 10.1136/thorax-2024-221778.
    >> Share

    November 2024
  91. PALJARVI T, Forton JT, Thompson C, Luciano S, et al
    Neuropsychiatric diagnoses after montelukast initiation in paediatric patients with asthma.
    Thorax. 2024 Nov 22:thorax-2024-221590. doi: 10.1136/thorax-2024-221590.
    >> Share

  92. EVANGELOPOULOS D, Zhang H, Chatzidiakou L, Walton H, et al
    Air pollution and respiratory health in patients with COPD: should we focus on indoor or outdoor sources?
    Thorax. 2024;79:1116-1123.
    >> Share

  93. HERMANN EA, Motahari A, Hoffman EA, Sun Y, et al
    Associations of pulmonary microvascular blood volume with per cent emphysema and CT emphysema subtypes in the community: the MESA Lung study.
    Thorax. 2024 Nov 4:thorax-2024-222002. doi: 10.1136/thorax-2024-222002.
    >> Share

    October 2024
  94. YEN FS, Hsu CC, Wei JC, Tsai FJ, et al
    Glucagon-like peptide-1 receptor agonists may benefit cardiopulmonary outcomes in patients with COPD.
    Thorax. 2024;79:1017-1023.
    >> Share

  95. PHILIP J, Chang YK, Collins A, Smallwood N, et al
    Consensus palliative care referral criteria for people with chronic obstructive pulmonary disease.
    Thorax. 2024;79:1006-1016.
    >> Share

  96. LO D, Lawson C, Gillies C, Shabnam S, et al
    Association between socioeconomic deprivation, ethnicity and health outcomes in preschool children with recurrent wheeze in England: a retrospective cohort study.
    Thorax. 2024;79:1050-1059.
    >> Share

    September 2024
  97. FILIPOW N, Turner S, Petsky HL, Chang AB, et al
    Variability in forced expiratory volume in 1 s in children with symptomatically well-controlled asthma.
    Thorax. 2024 Sep 27:thorax-2024-221755. doi: 10.1136/thorax-2024-221755.
    >> Share

  98. BRUSTAD N, Thorsen J, Pedersen CET, Ali M, et al
    Urban metabolic and airway immune profiles increase the risk of infections in early childhood.
    Thorax. 2024;79:943-952.
    >> Share

    August 2024
  99. NORDLUND B
    Inequalities in care and the burden of wheeze and asthma in young children from diverse socioeconomic and ethnic backgrounds.
    Thorax. 2024 Aug 17:thorax-2024-222111. doi: 10.1136/thorax-2024-222111.
    >> Share

    July 2024
  100. TATON O, Gevenois PA, Van Muylem A, Bondue B, et al
    Improvements of the shape and strength of the diaphragm after endoscopic lung volume reduction.
    Thorax. 2024;79:711-717.
    >> Share

  101. LICSKAI C, Hussey A, Rowley V, Ferrone M, et al
    Quantifying sustained health system benefits of primary care-based integrated disease management for COPD: a 6-year interrupted time series study.
    Thorax. 2024;79:725-734.
    >> Share

  102. GERSHON AS, Blazer A, Ko D
    Undertreating cardiovascular disease in people with chronic obstructive pulmonary disease (COPD).
    Thorax. 2024;79:705-706.
    >> Share

  103. GRANELL R, Haider S, Deliu M, Ullah A, et al
    Lung function trajectories from school age to adulthood and their relationship with markers of cardiovascular disease risk.
    Thorax. 2024;79:770-777.
    >> Share

  104. AMEGADZIE JE, Gao Z, Quint JK, Russell R, et al
    QRISK3 underestimates the risk of cardiovascular events in patients with COPD.
    Thorax. 2024;79:718-724.
    >> Share

  105. KARP T, Faiz A, van Nijnatten J, Kerstjens HAM, et al
    Nasal epithelial gene expression identifies relevant asthma endotypes in the ATLANTIS study.
    Thorax. 2024 Jul 15:thorax-2023-221230. doi: 10.1136/thorax-2023-221230.
    >> Share

    May 2024
  106. GHOSH M, Vladar EK
    Extensive airway remodelling in severe COPD imparts resiliency to environmental stressors.
    Thorax. 2024;79:491-492.
    >> Share

  107. KOEFOED HJL, Wang G, Gehring U, Ekstrom S, et al
    Clinical implications of airway obstruction with normal or low FEV(1) in childhood and adolescence.
    Thorax. 2024;79:573-580.
    >> Share

  108. LIANG C, Chung HF, Dobson A, Sandin S, et al
    Female reproductive histories and the risk of chronic obstructive pulmonary disease.
    Thorax. 2024;79:508-514.
    >> Share

  109. STOLERIU MG, Ansari M, Strunz M, Schamberger A, et al
    COPD basal cells are primed towards secretory to multiciliated cell imbalance driving increased resilience to environmental stressors.
    Thorax. 2024;79:524-537.
    >> Share

    April 2024
  110. JENKINS AR, Burtin C, Camp PG, Lindenauer P, et al
    Do pulmonary rehabilitation programmes improve outcomes in patients with COPD posthospital discharge for exacerbation: a systematic review and meta-analysis.
    Thorax. 2024;79:438-447.
    >> Share

  111. WU T, Santos S, Quezada-Pinedo HG, Vernooij MW, et al
    Body composition and respiratory outcomes in children: a population-based prospective cohort study.
    Thorax. 2024;79:448-456.
    >> Share

  112. GRUDZINSKA FS, Scott A
    Unravelling the neutrophil enigma: a new insight into RSV-induced bronchiolitis in infants.
    Thorax. 2024 Apr 4:thorax-2023-221130. doi: 10.1136/thorax-2023-221130.
    >> Share

    March 2024
  113. PETOUSI N, Pavord ID, Kent BD
    Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease.
    Thorax. 2024;79:291-292.
    >> Share

  114. CELIS-PRECIADO CA, Lachapelle P, Couillard S
    Blood eosinophils take centre stage in predicting the response to sublingual immunotherapy (SLIT): a familiar twist.
    Thorax. 2024;79:297-298.
    >> Share

  115. VOGIATZIS I
    Role of blood flow restriction strength training in chronic obstructive pulmonary disease.
    Thorax. 2024;79:289-290.
    >> Share

  116. COLAK Y, Afzal S, Marott JL, Vestbo J, et al
    Type-2 inflammation and lung function decline in chronic airway disease in the general population.
    Thorax. 2024;79:349-358.
    >> Share

  117. KOHLBRENNER D, Kuhn M, Manettas A, Aregger C, et al
    Low-load blood flow restriction strength training in patients with COPD: a randomised single-blind pilot study.
    Thorax. 2024;79:340-348.
    >> Share

  118. WANG KCW, Blakey JD
    Impacts of sex and gender on severe asthma.
    Thorax. 2024 Mar 7:thorax-2023-221117. doi: 10.1136/thorax-2023-221117.
    >> Share

  119. MORGAN AD
    Unravelling the obesity-asthma connection in childhood and adolescence: does body shape matter?
    Thorax. 2024 Mar 7:thorax-2023-221345. doi: 10.1136/thorax-2023-221345.
    >> Share

    February 2024
  120. WILKINSON AJK, Maslova E, Janson C, Radhakrishnan V, et al
    Greenhouse gas emissions associated with suboptimal asthma care in the UK: the SABINA healthCARe-Based envirONmental cost of treatment (CARBON) study.
    Thorax. 2024 Feb 27:thorax-2023-220259. doi: 10.1136/thorax-2023-220259.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016